GRCE Grace Therapeutics, Inc. - Common Stock
$2,18
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$2–$5
12% of range
Analystenbewertung
BUY
8 analysts
Kursziel
$6
+180% upside
P/E (TTM)
-9.9
ROE
-12.3%
Nettogewinnmarge
—
GRCE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.18
Marktkapitalisierung
—
P/E (TTM)
-9.9
EPS (TTM)
$-0.47
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-12.3%
Verschuldungsgrad
—
52W-Spanne
$2 – $5
GRCE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2021-03-31
→
2022-03-31
EPS
$-0.47
2022-03-31
→
2026-03-31
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
GRCE
Peer-Median
P/E (TTM)
-9.9
53.4
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
GRCE
Peer-Median
ROA
-11.2%
-17.4%
ROE
-12.3%
-29.0%
ROIC
-14.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
GRCE
Peer-Median
Current Ratio (Liquiditätsgrad)
8.1
2.3
Quick Ratio
7.9
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
GRCE
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
GRCE
Peer-Median
GRCE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
8 Analysten
- Starker Kauf 2 25,0%
- Kauf 5 62,5%
- Halten 1 12,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
2 Analysten · 2026-08-14
Median
$6.10
← Unter allen Zielen
$2.18
Tief
$4.08
Hoch
$8.12
Median-Ziel
$6.10
+179,8%
Mittelwert-Ziel
$6.10
+179,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.18%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.06 | $-0.23 | 0.17% |
| 31. Dezember 2025 | $-0.14 | $-0.29 | 0.15% |
| 30. September 2025 | $-0.06 | $-0.19 | 0.13% |
| 30. Juni 2025 | $-0.21 | $-0.22 | 0.01% |
| 31. März 2025 | $0.10 | $-0.32 | 0.42% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| GRCE | — | -9.9 | — | — | -12.3% | — |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| NTRB | — | — | — | — | — | — |
| CNTX | $135M | -3.9 | 112.7% | — | -50.5% | — |
| VERU | $56M | -5.4 | 3.6% | — | -115.4% | — |
| MIRA | $63M | -1.1 | -40.3% | -10557.5% | -190.5% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $100M | $196.0K | |
| Cost of Revenue | · | · | · | · | $0 | $76.0K | |
| R&D Expense | $2M | $10M | $5M | $10M | $6M | $4M | |
| SG&A Expense | $9M | $7M | $7M | $8M | $9M | $6M | |
| Operating Income | $-11M | $-17M | $-13M | $-52M | $-16M | $-16M | |
| Interest Income | $685.0K | $711.0K | $911.0K | $246.0K | $77.0K | $107.0K | |
| Other Non-op | $2M | $4M | $-2M | $184.0K | $5M | $-3M | |
| Pretax Income | $-9M | $-13M | $-15M | $-52M | $-10M | $-20M | |
| Income Tax | $-2M | $-3M | $-2M | $-10M | $-648.0K | $0 | |
| Net Income | $-8M | $-10M | $-13M | $-42M | $-10M | $-20M | |
| EPS (Basic) | $-0.47 | $-0.79 | $-1.35 | $-5.71 | $-0.27 | · | |
| EPS (Diluted) | $-0.47 | $-0.79 | $-1.35 | $-5.71 | $-0.27 | · | |
| Shares (Basic) | 16,510,632 | 12,087,270 | 9,529,123 | 7,435,472 | 36,841,762 | · | |
| Shares (Diluted) | 16,510,632 | 12,087,270 | 9,529,123 | 7,435,472 | 36,841,762 | · | |
| EBITDA | $-11M | $-17M | $-13M | $-52M | · | $-16M |
Bilanz 24
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $22M | $23M | $28M | $30M | $51M | |
| Short-term Investments | · | · | $0 | $15.0K | $13M | $10M | |
| Receivables | · | · | $722.0K | $802.0K | $548.0K | $530.0K | |
| Prepaid Expense | $383.0K | $453.0K | $283.0K | $598.0K | $720.0K | $343.0K | |
| Current Assets | $17M | $23M | $24M | $29M | $45M | $62M | |
| PP&E (Net) | $8.0K | $15.0K | $24.0K | $104.0K | $21M | · | |
| PP&E (Gross) | $22.0K | $26.0K | $722.0K | $713.0K | · | · | |
| Accum. Depreciation | $14.0K | $9.0K | $608.0K | $570.0K | $446.0K | · | |
| Goodwill | $8M | $8M | $8M | $8M | $13M | · | |
| Intangibles | $41M | $41M | $41M | $41M | $70M | · | |
| Total Assets | $67M | $72M | $73M | $79M | $129M | $62M | |
| Accounts Payable | $2M | $2M | $2M | $3M | $3M | $1M | |
| Accrued Liabilities | · | · | $176.0K | $946.0K | $296.0K | $607.0K | |
| Current Liabilities | $2M | $2M | $2M | $3M | $3M | $2M | |
| Capital Leases | · | · | $0 | $410.0K | $191.0K | · | |
| Deferred Tax | $612.0K | $2M | $6M | $7M | $17M | · | |
| Total Liabilities | $3M | $5M | $12M | $11M | $20M | $7M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $258M | $258M | $197M | |
| Paid-in Capital | $298M | $293M | $279M | $14M | $12M | $11M | |
| Retained Earnings | $-228M | $-221M | $-211M | $-198M | $-156M | $-146M | |
| AOCI | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Stockholders' Equity | $64M | $67M | $62M | $68M | $108M | $56M | |
| Liabilities + Equity | $67M | $72M | $73M | $79M | $129M | $62M | |
| Shares Outstanding | 16,024,026 | 13,718,106 | 9,399,404 | 7,435,533 | 44,288,183 | · |
Cashflow 10
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $798.0K | $730.0K | $913.0K | $2M | $1M | $1M | |
| Deferred Tax | $-2M | $-3M | $-2M | $-10M | $-648.0K | $0 | |
| Amort. of Intangibles | · | · | · | · | $0 | $781.0K | |
| Operating Cash Flow | $-9M | $-15M | $-12M | $-16M | $-17M | $-14M | |
| Investing Cash Flow | $0 | $0 | $104.0K | $13M | $-4M | $-10M | |
| Stock Issued | · | · | $0 | $304.0K | $0 | $59M | |
| Net Stock Activity | · | · | $0 | $304.0K | · | $59M | |
| Financing Cash Flow | $4M | $14M | $7M | $304.0K | $0 | $59M | |
| Net Change in Cash | $-5M | $-872.0K | $-5M | $-2M | $-21M | $37M | |
| Taxes Paid | $12.0K | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -8377.0% | |
| Net Margin | · | · | · | · | · | -10039.8% | |
| Pretax Margin | · | · | · | · | · | -10039.8% | |
| EBITDA Margin | · | · | · | · | · | -8377.0% | |
| ROA | -11.2% | -13.2% | -16.9% | -40.8% | · | -46.1% | |
| ROE | -12.3% | -16.1% | -20.3% | -51.5% | · | -48.4% | |
| ROIC | -14.2% | -18.8% | -18.2% | -62.7% | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 11.8 | 14.3 | 8.6 | · | 39.5 | |
| Quick Ratio | 7.9 | 11.5 | 14.1 | 8.4 | · | 38.8 |
Effizienz 2
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 0.4 |
Wachstumsraten 1
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 50920.4% | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $100M | $196.0K | |
| Net Income TTM | $-8M | $-10M | $-13M | $-42M | $-10M | $-20M | |
| Market Cap | · | · | $32M | $123M | · | · | |
| P/E | -9.9 | -2.9 | -2.5 | -0.5 | -27.1 | · | |
| P/B | · | · | 0.5 | 1.8 | · | · | |
| P / Tangible Book | · | · | 2.6 | 6.6 | · | · | |
| P / Cash Flow | · | · | -2.6 | -7.7 | · | · | |
| Earnings Yield | -10.2% | -34.6% | -39.4% | -206.9% | -3.7% | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $697.0K | $420.0K | $462.0K | $568.0K | $955.0K | $2M | $2M | $3M | $3M | $2M | $1M | $460.0K | $1M | $2M | $2M | $3M | |
| SG&A Expense | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Income | $-16M | $-3M | $-2M | $-3M | $-3M | $-3M | $-4M | $-5M | $-5M | $-3M | $-3M | $-2M | $-4M | $-38M | $-4M | $-5M | |
| Interest Income | $141.0K | $138.0K | $170.0K | $172.0K | $205.0K | $166.0K | $138.0K | $172.0K | $235.0K | $249.0K | $316.0K | $212.0K | $134.0K | $111.0K | $67.0K | $36.0K | |
| Other Non-op | $127.0K | $131.0K | $134.0K | $2M | $-272.0K | $3M | $-1M | $547.0K | $2M | $-792.0K | $444.0K | $-2M | $142.0K | $114.0K | $82.0K | $24.0K | |
| Pretax Income | $-16M | $-3M | $-2M | $-938.0K | $-3M | $-382.0K | $-5M | $-4M | $-3M | $-4M | $-3M | $-4M | $-4M | $-38M | $-4M | $-5M | |
| Income Tax | $0 | $-2M | $0 | $0 | $0 | $-1M | $-605.0K | $-852.0K | $-724.0K | $-889.0K | $-208.0K | $-446.0K | $-289.0K | $-9M | $-274.0K | $-155.0K | |
| Net Income | $-16M | $-1M | $-2M | $-938.0K | $-3M | $636.0K | $-4M | $-3M | $-3M | $-3M | $-2M | $-3M | $-4M | $-29M | $-4M | $-5M | |
| EPS (Basic) | $-0.91 | $-0.06 | $-0.14 | $-0.06 | $-0.21 | $0.11 | $-0.36 | $-0.30 | $-0.24 | $-0.17 | $-0.21 | $-0.43 | $-0.54 | $-3.92 | $-0.52 | $-0.66 | |
| EPS (Diluted) | $-0.91 | $-0.06 | $-0.14 | $-0.06 | $-0.21 | $0.11 | $-0.36 | $-0.30 | $-0.24 | $-0.17 | $-0.21 | $-0.43 | $-0.54 | $-3.92 | $-0.52 | $-0.66 | |
| Shares (Basic) | 17,269,986 | -32,272,032 | 16,933,620 | 15,924,522 | 15,924,522 | -21,853,741 | 11,506,234 | 11,506,234 | 10,928,543 | -16,965,344 | 11,506,257 | 7,552,677 | 7,435,533 | -14,813,231 | 7,435,472 | 7,425,166 | |
| Shares (Diluted) | 17,269,986 | -32,272,032 | 16,933,620 | 15,924,522 | 15,924,522 | -21,853,741 | 11,506,234 | 11,506,234 | 10,928,543 | -16,965,344 | 11,506,257 | 7,552,677 | 7,435,533 | -14,813,231 | 7,435,472 | 7,425,166 | |
| EBITDA | $-16M | · | $-2M | · | $-3M | · | · | $-5M | $-5M | · | $-3M | $-2M | $-4M | · | $-4M | $-5M |
Bilanz 24
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $17M | $19M | $17M | $20M | $22M | $11M | $15M | $19M | $23M | $19M | $27M | $22M | $28M | $26M | $35M | |
| Short-term Investments | · | · | · | · | · | · | · | $15.0K | $15.0K | · | $7M | $15.0K | $15.0K | $15.0K | $5M | $14.0K | |
| Receivables | · | · | · | · | · | · | · | · | $398.0K | · | $959.0K | $837.0K | $837.0K | $802.0K | $778.0K | $859.0K | |
| Prepaid Expense | $557.0K | $383.0K | $519.0K | $416.0K | $500.0K | $453.0K | $583.0K | $477.0K | $622.0K | $283.0K | $811.0K | $1M | $1M | $598.0K | $1M | $1M | |
| Current Assets | $14M | $17M | $19M | $17M | $21M | $23M | $12M | $16M | $20M | $24M | $27M | $29M | $24M | $29M | $33M | $38M | |
| PP&E (Net) | · | $8.0K | · | · | · | $15.0K | · | · | · | $24.0K | · | · | · | $104.0K | · | · | |
| PP&E (Gross) | · | $22.0K | · | · | · | $26.0K | · | · | · | $722.0K | · | · | · | $713.0K | · | · | |
| Accum. Depreciation | · | $14.0K | · | · | · | $9.0K | · | · | · | $608.0K | · | · | · | $570.0K | · | · | |
| Goodwill | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $13M | $13M | |
| Intangibles | $28M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $70M | $70M | |
| Total Assets | $50M | $67M | $68M | $67M | $70M | $72M | $61M | $65M | $70M | $73M | $76M | $78M | $73M | $79M | $117M | $121M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $1M | $2M | $3M | $3M | $4M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $814.0K | · | $532.0K | $460.0K | $994.0K | $946.0K | · | · | |
| Current Liabilities | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $1M | $2M | $3M | $3M | $4M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $410.0K | $430.0K | $450.0K | |
| Deferred Tax | $612.0K | $612.0K | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | $16M | $16M | |
| Total Liabilities | $2M | $3M | $4M | $4M | $6M | $5M | $9M | $9M | $10M | $12M | $12M | $11M | $9M | $11M | $20M | $21M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | $1.0K | · | · | $258M | · | $258M | $258M | |
| Paid-in Capital | $299M | $298M | $298M | $294M | $294M | $293M | $279M | $18M | $18M | $279M | $18M | $17M | $14M | $14M | $14M | $13M | |
| Retained Earnings | $-244M | $-228M | $-227M | $-225M | $-224M | $-221M | $-221M | $-217M | $-214M | $-211M | $-208M | $-206M | $-202M | $-198M | $-169M | $-165M | |
| AOCI | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Stockholders' Equity | $48M | $64M | $65M | $63M | $64M | $67M | $52M | $56M | $59M | $62M | $65M | $67M | $64M | $68M | $97M | $100M | |
| Liabilities + Equity | $50M | $67M | $68M | $67M | $70M | $72M | $61M | $65M | $70M | $73M | $76M | $78M | $73M | $79M | $117M | $121M | |
| Shares Outstanding | 16,274,026 | · | 15,474,026 | 14,128,562 | 13,828,562 | · | 10,139,861 | · | · | · | · | · | 7,435,533 | 7,435,533 | · | · |
Cashflow 8
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $105.0K | $182.0K | $108.0K | $206.0K | $302.0K | $130.0K | $160.0K | $202.0K | $238.0K | $229.0K | $326.0K | $280.0K | $78.0K | $322.0K | $443.0K | $582.0K | |
| Deferred Tax | · | $-2M | $0 | $0 | $0 | $-1M | $-605.0K | $-852.0K | $-724.0K | $-891.0K | $-208.0K | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-3M | $-2M | $-3M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-6M | $-3M | $-4M | $-3M | |
| Investing Cash Flow | · | $0 | $0 | $0 | $0 | $0 | $15.0K | $0 | $-15.0K | $7M | $-7M | $110.0K | $0 | $5M | $-5M | $-96.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $109.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $0 | $0 | $4M | $0 | $-327.0K | $14M | $0 | $0 | $0 | $0 | $0 | $7M | $0 | $0 | $0 | $109.0K | |
| Net Change in Cash | $-3M | $-2M | $2M | $-3M | $-2M | $11M | $-4M | $-4M | $-4M | $4M | $-8M | $5M | $-6M | $2M | $-9M | $-3M |
Rentabilität 3
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -26.3% | · | -3.6% | · | -4.8% | · | · | -4.8% | -3.7% | · | -2.5% | -3.3% | -4.1% | · | -3.4% | -4.1% | |
| ROE | -28.3% | · | -4.0% | · | -5.5% | · | · | -5.6% | -4.2% | · | -3.0% | -3.9% | -4.8% | · | -3.7% | -4.6% | |
| ROIC | -33.0% | · | -3.8% | · | -4.9% | · | · | -6.9% | -6.6% | · | -4.3% | -2.8% | -6.5% | · | -4.1% | -5.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | · | 15.0 | · | 8.9 | · | · | 6.0 | 7.9 | · | 15.2 | 20.7 | 12.0 | · | 9.7 | 9.9 | |
| Quick Ratio | 11.0 | · | 14.5 | · | 8.6 | · | · | 5.7 | 7.6 | · | 14.7 | 19.9 | 11.4 | · | 9.3 | 9.4 |
Bewertung (TTM) 7
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-22M | · | $-11M | $-12M | $-14M | · | $-13M | $-12M | $-12M | · | $-14M | $-16M | $-17M | · | $-17M | $-12M | |
| Market Cap | $37M | · | $54M | · | $41M | · | · | · | · | · | · | · | $24M | · | · | · | |
| P/E | -1.7 | · | -4.5 | -3.2 | -2.7 | · | -3.4 | -2.5 | -2.1 | · | -1.7 | -1.3 | -1.4 | · | -1.6 | -2.5 | |
| P/B | 0.8 | · | 0.8 | · | 0.6 | · | · | · | · | · | · | · | 0.4 | · | · | · | |
| P / Tangible Book | 3.0 | · | 3.4 | 3.1 | 2.9 | · | 13.2 | · | · | · | · | · | 1.6 | · | · | · | |
| P / Cash Flow | -11.5 | · | · | · | -22.8 | · | · | · | · | · | · | · | -3.8 | · | · | · | |
| Earnings Yield | -58.1% | · | -22.2% | -31.2% | -37.4% | · | -29.7% | -39.3% | -48.6% | · | -58.8% | -77.3% | -73.3% | · | -62.7% | -39.9% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Umsatz | — | — | — | — | $100M |
| Nettoergebnis | $-8M | $-10M | $-13M | $-42M | $-10M |
| Verwässerte EPS | $-0.47 | $-0.79 | $-1.35 | $-5.71 | $-0.27 |
Bilanz
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 8.1 | 11.8 | 14.3 | 8.6 | — |
| Quick Ratio | 7.9 | 11.5 | 14.1 | 8.4 | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 37 Einreicher · $9.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 14 (-6 vs. Vorquartal) | 11 (+6 vs. Vorquartal) | 11 (+6 vs. Vorquartal) | 5 (0 vs. Vorquartal) | -618K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Cerity Partners LLC | $1.927.355 | 849.055 | 20,50% | Aktien |
| Eversept Partners, LP | $1.754.483 | 772.900 | 18,66% | Aktien |
| VANGUARD GROUP INC | $1.449.156 | 415.231 | 15,42% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.122.964 | 494.698 | 11,95% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $934.591 | 411.714 | 9,94% | Aktien |
| Maven Securities LTD | $454.000 | 200.000 | 4,83% | Aktien |
| Birchview Capital, LP | $272.400 | 120.000 | 2,90% | Aktien |
| CANTOR FITZGERALD, L. P. | $227.000 | 100.000 | 2,41% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $219.940 | 96.890 | 2,34% | Aktien |
| JANE STREET GROUP, LLC | $163.667 | 72.100 | 1,74% | Kaufoption |
| XTX Topco Ltd | $162.686 | 71.668 | 1,73% | Aktien |
| JANE STREET GROUP, LLC | $142.075 | 62.588 | 1,51% | Aktien |
| CITADEL ADVISORS LLC | $119.175 | 52.500 | 1,27% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $112.540 | 49.577 | 1,20% | Aktien |
| Rangeley Capital, LLC | $59.020 | 26.000 | 0,63% | Aktien |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $52.210 | 23.000 | 0,56% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $29.510 | 13.000 | 0,31% | Kaufoption |
| Stratos Investment Management, LLC | $25.329 | 11.158 | 0,27% | Aktien |
| CITADEL ADVISORS LLC | $24.947 | 10.990 | 0,27% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $23.835 | 10.500 | 0,25% | Aktien |
| Scientech Research LLC | $23.118 | 10.184 | 0,25% | Aktien |
| OPPENHEIMER & CO INC | $22.700 | 10.000 | 0,24% | Aktien |
| MORGAN STANLEY | $21.447 | 9.448 | 0,23% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $19.863 | 8.750 | 0,21% | Aktien |
| UBS Group AG | $13.620 | 6.000 | 0,14% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $6.084 | 2.680 | 0,06% | Aktien |
| BlackRock, Inc. | $5.328 | 2.347 | 0,06% | Aktien |
| WELLS FARGO & COMPANY/MN | $4.086 | 1.800 | 0,04% | Aktien |
| Tower Research Capital LLC (TRC) | $3.523 | 1.552 | 0,04% | Aktien |
| Arax Advisory Partners | $2.270 | 1.000 | 0,02% | Aktien |
| ROYAL BANK OF CANADA | $1.000 | 543 | 0,01% | Aktien |
| Activest Wealth Management | $236 | 104 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $175 | 77 | 0,00% | Aktien |
| HRT FINANCIAL LP | $142 | 62.691 | 0,00% | Aktien |
| Federation des caisses Desjardins du Quebec | $93 | 41 | 0,00% | Aktien |
| Virtu Financial LLC | $23 | 10.166 | 0,00% | Aktien |
| LANARK FINANCIAL, INC. | $4 | 2 | 0,00% | Aktien |
Unternehmensinsider 17 Insider · 8 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Prashant Kohli | Chief Executive Officer | 14. April 2025 A | — | 0 | 0 | $0 |
| Janelle D'Alvise | PRESIDENT & CEO | 22. Juni 2022 A | — | 0 | 0 | $0 |
| Brian D. Ford | CHIEF FINANCIAL OFFICER | 22. Juni 2022 A | — | 0 | 0 | $0 |
| Pierre Lemieux | COO, Canada & CSO | 22. Juni 2022 A | — | 0 | 0 | $0 |
| Amresh Kumar | VP Program Management | 14. April 2025 A | — | 0 | 0 | $0 |
| Carrie D'Andrea | VP Clinical Operations | 14. April 2025 A | — | 0 | 0 | $0 |
| Robert J Delaversano | Principal Financial Officer | 14. April 2025 A | — | 0 | 0 | $0 |
| Loch R. Macdonald | Chief Medical Officer | 14. April 2025 A | — | 0 | 0 | $0 |
| George Kottayil | Direktor | 8. Januar 2026 A | — | 0 | 0 | $0 |
| Vimal Kavuru | Direktor | 8. Januar 2026 A | 1.188.076 | 0 | 0 | $0 |
| Edward Neugeboren | Direktor | 8. Januar 2026 A | — | 0 | 0 | $0 |
| Brian A Davis | Direktor | 8. Januar 2026 A | — | 0 | 0 | $0 |
| Donald Olds | Direktor | 31. August 2023 P | 381 | 0 | 0 | $0 |
| Michael Derby | Direktor | 14. Juli 2023 A | — | 0 | 0 | $0 |
| John Canan | Direktor | 28. September 2022 A | — | 0 | 0 | $0 |
| Roderick Noel Carter | Direktor | 12. November 2021 A | — | 0 | 0 | $0 |
| William A Haseltine | Direktor | 12. November 2021 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) | 1. August 2019 | — | Erste Einreichung | — | SEC |
| Neptune Technologies & Bioressources Inc. | 9. September 2015 | — | Erste Einreichung | — | SEC |
| Neptune Technologies & Biouressources Inc. | 18. Dezember 2013 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.